Sanofi rebuffs renewed Lantus cancer worries | Reuters
Links shared publicly online about this topic.
- 0total visits
Sanofi rebuffs renewed Lantus cancer worries | Reuters
LONDON (Reuters) - A Swedish study has rekindled concerns about a possible link between Sanofi's top-selling insulin drug Lantus and cancer, but the French drugmaker said on Wednesday the observational
View full resource at reuters.com
Tags: Diabetes Type 1 Medication, Diabetes Type 2 Medication, Diabetes Medication, Insulin, Cancer, Drug, Lantus, Sanofi-Aventis
Most Recently Shared on December 7, 2011 at 12:55 pm By:
Sanofi rebuffs renewed Lantus cancer worries - LONDON (Reuters) - A Swedish study has rekindled concerns about a pos... http://t.co/32t0QRZ3
Also Shared By:
Advertisement
Health News OW
@Health_News_OW
Sanofi rebuffs renewed Lantus cancer worries: LONDON (Reuters) - A Swedish study has rekindled concerns about a ... http://t.co/QMPYBKTe
1 year ago...